PPP1R1B and Alzheimer disease: To understand the mechanism of the decrease in the DARPP-32 level in AD, we examined the DARPP-32 protein level in primary neurons and SH-SY5Y cells treated with OA or Aβ peptides, which have previously been used to mimic AD pathology in cell culture models.